Latest Tenders in Germany

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Brinzolamide + Brimonidine, Atc S01ec24 for the Period September 1St, 2024 - August 31St, 2026

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Dapagliflozin (A10bk01) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Evolocumab (C10ax13) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Midazolam (N05cd08) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Contracts in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Interferon Beta-1A, Intramuscular Injection (L03ab07) as Part of a So-Called O...

Open House Drug Discount Agreements Emtricitabine, Tenofovir Disoproxil and Rilpivirine, Atc J05ar08

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Sodium Oxybate (N07xx04) as Part of a So-Called Open House Model.

Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Drug Name Botox(R), Atc M03ax21

Open House Drug Discount Agreements Dexamethasone as an Intravitreal Implant, Atc S01ba01

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Lanthanum (Iii) Carbonate, only Chewable Tablets (V03ae03) as Part of a So-Called Open-Ho...